Transgenic mice designated aMUPA overproduce in many brain sites the urokinase-type plasminogen activator (uPA), a protease implicated in fibrinolysis and extracellular proteolysis. Here we report that, compared to their parental wild-type control, aMUPA mice spontaneously consumed less food (=20%), exhibited reduced body weight (=20%) and length (^6%), and also prolonged life span ("=20%). The aMUPA phenotype is thus reminiscent of experimental animals in which dietary restriction enhances longevity. Reduced eating and body weight were observed in aMUPA mice shortly after weaning, and these levels were maintained virtually throughout their lifetime. aMUPA mice also exhibited lower levels of blood sugar (=9%), smaller litter size (=14%), and lower birth frequency (=10%). In the adult aMUPA brain, uPA mRNA has been localized through in situ hybridization also in neuronal cells of the hypothalamic paraventricular nucleus, a region implicated in feeding behavior. No signals ofuPA mRNA could be detected in the paraventricular nucleus of control mice. It is suggested that in aMUPA mice, overproduction ofuPA in brain sites controlling feeding leads to reduced food consumption that, in turn, results in retardation of growth and body weight and also in increased longevity. The aMUPA experimental model may have implications for normal mice.
P LASMINOGEN activators (PAs) are secreted serine proteases that specifically generate plasmin from the inactive zymogen plasminogen, which is abundant in body fluids. Plasmin is a trypsin-like general protease that dissolves the fibrin network of the blood clot. Plasmin is also capable of cleaving extracellular proteins either directly or through the activation of metalloprotease proenzymes. The PA-initiated proteolytic cascade has been implicated in diverse events in blood and tissues, including fibrinolysis, cell migration, ovulation, inflammation, tissue repair and remodeling, and embryonal development. Accordingly, PAs are synthesized and secreted in various cell types in response to appropriate hormones, growth factors, cytokines, and other modulators. Two distinct molecular types of PA exist in mammals, the urokinase-type (uPA) and the tissue-type (tPA), encoded by two different genes. Other important components of the plasminogen activation system are specific inhibitors of the catalytic activities and a high-affinity surface receptor for uPA found in many cell types. The multiple controls, at the level of genes and enzymes, adjust PA-initiated proteolytic cascade according to specific local and temporal needs (for reviews on the PA/plasmin system, see Reich, 1978; Dan0 et al., 1985; Saksela and Rifkin, 1988; Vassalli et al., 1991; Blasi, 1993; Collen and Lijnen, 1994; Carmelietetal., 1995) .
In the nervous system, PA activity has been claimed to play a role during axonal growth, development, and regeneration (for reviews, see Romanic and Madri, 1994; Smirnova et al., 1994 ; and an extensive list of references in Masos and Miskin, 1996) . In the mature rat brain, tPA was induced during seizure-like states and has therefore been suggested to play a role in neuronal plasticity coupled to neuronal activity (Qian et al., 1993) . The detection of uPA mRNA through in situ hybridization in the hippocampal formation of normal mice (Masos and Miskin, 1996) has led us to suggest that the enzyme could play a role in hippocampal functioning, including learning and memory. This notion is supported by our study on transgenic mice designated aMUPA (Miskin et al., 1990) . In these mice, overexpression of uPA in sites related to learning and memory (i.e., hippocampus, amygdala and neocortex) coincides with impairment in several learning tasks (Meiri et al., 1994) .
aMUPA transgenic mice were originally generated as a tool to investigate the possible effects of uPA in the eye, and have previously been described (Miskin et al., 1990 (Miskin et al., , 1991 . These mice carry the murine uPA cDNA linked downstream from the promoter of the murine aA-crystallin gene known to be active predominantly in the ocular lens. Unexpectedly, in addition to the lens, aMUPA mice produced transgenic uPA in an ectopic manner, specifically in nerve cells in the central nervous system (i.e., brain, spinal cord, and retina). No ectopic transgenic expression was found in the peripheral nervous system or in nonneuronal tissues. In the aMUPA brain, neuronal cells producing transgenic uPA mRNA were detected through in situ hybridization in many areas (Meiri et al., 1994; Masos, T., and Miskin, R., unpublished results) . aMUPA mice thus provide a unique experimental system by which to explore consequences of excess uPA in the brain.
Here we describe several phenotypic alterations found in aMUPA mice: spontaneous reduction of food consumption, retardation of growth and body weight, and increased longevity. It is suggested that expression of transgenic uPA in the hypothalamic paraventricular nucleus (PVN), a structure implicated in feeding control (for a review, see Morley, 1987) , could lead to the above phenotypic changes.
METHODS
Transgenicmice.
•-Transgenic mice designated aMUPA were generated by Miskin et al. (1990) from the NIH FVB/N inbred mouse line as previously described. Histological examination of aMUPA tissues including brain did not reveal any abnormality. Throughout this study one line of aMUPA mice was used; unless stated otherwise, mice were in the homozygous state. aMUPA and parental wild-type (WT) control mice were propagated and maintained at the Weizmann Institute Transgenic Mouse Facilities according to the National Institutes of Health Guide for Care and Use of Laboratory Animals. The mice were housed as follows: either 5 mice in small cages or 10 mice in large cages, at 23°C, under a 12-h light/ 12-h dark cycle with water and food ad libitum, unless otherwise stated. Mice were fed with Experimental Animal Center Mice and Rat Breeding Diet, which included corn, soybeans, bran, corn oil, salts, vitamins, and amino acids (analysis: protein, 21%; carbohydrates, 48.1%; Ca, 0.8%; P, 0.6%; Mn, 95 g/ton; fat, 7%; ash, 8.5%; cellulose, 4%; humidity, 10%). Female mice were used for all experiments at the indicated ages.
In situ hybridization. -Preparation of mouse brain sections, hybridization protocol, and riboprobes at the sense and antisense orientation were as described by Meiri et al. (1994) . Temperature of prehybridization, hybridization, and wash was as described by Masos and Miskin (1996) .
Statistical analysis. -Methods for statistical evaluation are specified for each case. When not specifically mentioned, comparison of two groups was conducted through the unpaired Mest, and comparison between three or more groups was done through one-way analysis of variance (ANOVA) followed by Fisher protected least significant difference (PLSD) when needed, with a per-experiment level of significance at .05 (Winer, 1971) .
Blood glucose determination.
-Mouse blood samples were tested with the ONE TOUCH blood glucose monitoring system (Lifescan Inc., Mountain View, CA). For each mouse, blood sampling was conducted only once during each 24-h period.
RESULTS
aMUPA mice exhibit reduced body weight and length. -While working with aMUPA mice, we noticed that they looked smaller compared to age-matched WT control mice. We therefore determined body weight at different mouse ages for the entire available animal stock of WT and homozygous aMUPA mice which included a large number of animals derived from many litters. Results are presented in Figure 1A . Compared to WT, homozygous aMUPA mice exhibited reduced body weight throughout most of their life span. Weight differences were first noticed shortly after weaning (Figure 1 A, inset) and could not be detected prior to it. The mean aMUPA body weight was 86% of control at 1-2 months of age (/?-value for the Mest was .0001), 76% at 4.5-5 months (p = .0001), 79% at 15 months (p = .0001), and 87% at 18-19 months of age (p = .0024). At 28 months no difference between the two mouse groups could be noticed, mainly due to weight loss occurring in WT.
Body weight of heterozygous aMUPA mice (F,) was also investigated. Body weight of F, mice was followed in a longitudinal manner and compared to that of age-matched WT and homozygous aMUPA mice maintained during the same 9-month period. F, body weight values fell roughly intermediate between those of homozygous aMUPA and WT mice ( Figure IB ).
Body length of aMUPA homozygous mice was also reduced compared to WT, although to a lesser degree than Each point represents the mean weight ± SE of 18-50 mice. At each age the three mouse groups were compared through the one-way ANOVA followed by Fisher protected LSD with per-experiment level of significance of a = .05 (Winer, 1971) . At 3, 5, 7, and 8 months of age all groups were significantly different (p = .0001 for each age). At the other ages, either no significant difference was found between all three groups, or only one group was significantly different from the two other groups. weight ( Figure 2 ). At 6 months of age aMUPA were about 6% shorter than WT, whereas body weight of the same group was 20% lower.
aMUPA mice exhibit reduced food consumption. -The phenotypic changes in body weight and length found in aMUPA mice prompted us to follow-up their food intake. The daily food consumption for both mouse types was determined throughout a 30-to 145-day period (Figure 3 ). Although consecutive measurements showed large variation, the data indicate that aMUPA consumed less food daily throughout the entire experimental period, starting immediately after weaning. Comparison of the two mouse types for their mean daily food intake in each of the age periods of 30-60, 60-90, and 90-145 days indicated that aMUPA ate, respectively, 85%, 77%, and 78% of WT consumption (^-values for the Mest were, respectively, .0001, .0005, and .0001). We also compared the mice at 16 months of age and found that aMUPA ate 69% of WT consumption (data not shown). It also appeared from the data that the daily food intake of aMUPA declined with time more than that of WT. However, this difference between the two mouse types did not quite attain significance (p = .10 for comparison of slopes in Figure 3) , and further experiments are needed to critically test this issue.
To determine whether the amount of food consumed by aMUPA could account for the weight difference found between aMUPA and WT mice, a group of WT mice was fed with food availability limited to the voluntary daily consumption of aged-matched aMUPA mice. Immediately after weaning, WT mice were divided into two groups, one fed ad libitum (WT-1) and the other (WT-2) fed daily the amount consumed by aged-matched aMUPA. The amount of food was determined as described for Figure 3 . Results are presented in Figure 4 . During the experimental period of 145 days both aMUPA and WT mice that were fed ad Figure 2 . Measurements of body length and weight. Six-month-old female aMUPA and WT mice were examined, 17 mice in each group. Body length included tail. Columns represent mean values ± SD. Light columns, WT; dark columns, aMUPA. *Significantly different (p = .0001 for A and B) according to the two-group Mann-Whitney U-test (Hollander and Wolfe, 1973 Figure 3. Determination of food consumption of aMUPA and WT mice at different mouse ages. Immediately after weaning, 20 mice of each aMUPA and WT group, including the WT-1 and aMUPA mice used in Figure 4 , were fed a known excess amount of food per cage and allowed to eat ad libitum. Mice of each type were kept in two cages holding 8 and 12 mice. The points represent the average food intake per mouse per single cage. Twice a week the amount of food left in each cage was weighed, and the mean amount of food eaten per mouse per day was determined. The curves were estimated by linear regression model (using the method of least squares). 
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Figure 4. Effect of restricted diet on WT body weight. Immediately after weaning, 24 WT mice were divided into two equal groups (WT-1 and WT-2). WT-1 and 12 aged-matched aMUPA mice were fed ad libitum, and the amount of food eaten bv aMUPA and WT-1 was determined twice a week, as described for Figure 3 . WT-2 were provided a single daily meal at 900 h that consisted of the amount of food that was last found to be consumed by aMUPA in the same experiment. Body weight measurements of all mice were conducted every 2-4 weeks. Each point represents mean body weight ± SE. Each one of the four last values of each group was significantly different (p = .0001) from the counterpart values of the two other groups according to ANOVA (a = .05). B121 in mice and rats (for reviews, see Masoro, 1992 Masoro, , 1993 . It was therefore of interest to examine the longevity of aMUPA mice, which spontaneously eat less than nontransgenic controls. We generated survival curves for aMUPA and WT mice, 33 mice in each group, which were maintained in our stock for up to 37 months ( Figure 5 ). At that age the surviving animals (one WT and two aMUPA) were sacrificed; therefore we did not follow the maximum length of life. The aMUPA survival curve differed significantly from that of WT (p = .0001). The ages of 75th, 50th (median), and 25th percentile survivors were significantly longer (36%, 16%, and 23%, respectively) for aMUPA compared to WT. Taken together, these and the above results indicate that in aMUPA increased longevity coincides with reduced eating.
Comparison of aMUPA and WT mice for blood glucose level and several reproduction parameters. -Reduction of plasma glucose concentration occurred in diet-restricted rats and was suggested to contribute to life-span expansion (Masoro, 1993; Masoro et ah, 1995) . We therefore com- Age (months) Figure 5 . Survival curves of aMUPA and WT mice. Percentage of aMUPA and WT mice (33 in each group) surviving at the end of each month is indicated in the curves. At the age of 33 months one WT and seven aMUPA mice were removed for other purposes. The rest of the mice were followed up until the age of 37 months, and then the remaining animals, one WT and two aMUPA, were sacrificed. The survival curves and the 75th, 50th (median), and 25th percentile survivors were estimated using productlimit method, and the curves were compared using Wilcoxon test (Lawless, 1982) (p = -0001). pared aMUPA and WT for blood sugar level. Measurements were conducted for 5-month-old mice that were used in the restriction diet experiment presented in Figure 4 , including the restricted diet WT-2 group. Blood samples were taken at four different times during the day, including samples of WT-2 just before the supply of their daily meal and also 2 h later. Results are presented in Table 1 . WT-1 and aMUPA exhibited slight daily variations, with a highest sugar level detected at 1700 h. However, at all times aMUPA values were lower compared to WT-1, with the highest difference (12%) found at 1700 h. In WT-2, the glucose levels were at all times lower than in WT-1, except in the sample taken 2 h after eating, in accordance with published data (Masoro et ah, 1995) . This also was the only time when WT-2 exhibited a higher glucose level compared to aMUPA. At all other times WT-2 glucose was either similar or lower than that of aMUPA (Table 1) .
Animals kept under restricted food supply have been shown to manifest changes in female reproductive functions (Merry and Holehan, 1979) . Accordingly, aMUPA and WT mice were compared for several features: litter size, frequency of births (Table 2) , the age at which reproductive activities started in males and females, and duration of fertility of mates of each mouse group. aMUPA mice exhibited 12% less frequent births compared to WT. Further, the average litter size of aMUPA mice up to the age of 150 days was found to be 86% that of control. At about this age litter size started to gradually decline in both WT and aMUPA, and no significant differences between the two groups could be noticed (data not shown). The aforementioned differences between the mice were statistically significant (Table 2) . By contrast, no difference between the two mouse types could be found in the start of reproductive activity and duration of fertility (data not shown).
aMUPA mice produce transgenic uPA mRNA in the hypothalamic PVN. -Whole aMUPA and WT brains were analyzed through in situ hybridization for cells producing uPA mRNA, using riboprobes that could enlight both the transgenic and the normal uPA mRNA (Masos, T., and Miskin, R., unpublished results) . In the aMUPA brain, nerve cells labeled for uPA mRNA were detected in many sites. Given the results presented above, it was of interest to examine transgenic expression specifically in areas claimed •Data are presented in mg/dL; reported as mean ± SE. Means within the same time followed by the same letter are not significantly different according to ANOVA, followed by Fisher's PLSD (with per-experiment level of significance .05). p-values for the ANOVA were as follows: 900 h, p = .0001; 1100 h, /; = .006; 1700 h,p = .0001; 2100 h,p = .0008. to be involved in food consumption. Thus, in the hypothalamus only two nuclei were distinctly labeled for uPA mRNA: the hypothalamic PVN implicated in food consumption (Morley, 1987) and the supra-chiasmatic nucleus associated with circadian behavior (Akabayashi et al., 1994b) . In other hypothalamic areas cells showing hybridization signals were randomly dispersed rather than confined to specific hypothalamic nuclei. Figure 6 shows brain sections through the PVN, where hybridization signals were detected in aMUPA (Figure 6 A-C) but not in WT mice ( Figure 6E ). In aMUPA, signals were seen with the antisense riboprobe but not with the sense riboprobe ( Figure 6D ), indicating specificity for uPA mRNA. Cells exhibiting hybridization signals could be recognized as neurons at high magnification according to morphological appearance ( Figure 6B ). As with other brain (days ± SE) 23.6 ± 0.7 (100%) 26.4 ± 0.9 (112%) .0142 Litter size c (mean ± SE) 8.5 ± 0.2 (100%) 7.3 ± 0.2 (86%) .0001 */;-value for the unpaired /-test. "Thirty WT and 22 aMUPA females were mated with males of the same mouse type and followed up for frequency of births until the age of 8-10 months. regions in aMUPA mice, only a fraction of the neuronal population in the PVN yielded uPA mRNA signals.
DISCUSSION
Our data show that the transgenic state of aMUPA mice leads to alteration of both feeding behavior and longevity. Food consumption was reduced in the transgenic mice compared to WT mice, and life span was prolonged. This inverse relation between food consumption and longevity is in accordance with the well-established findings that dietary restriction retards the aging process in laboratory rats and mice (for reviews, see Masoro, 1992 Masoro, , 1993 . It is therefore very likely that in aMUPA the spontaneous decline in feeding is causally related not only to the retardation of growth and body weight, but also to increased longevity. It is of interest to note that in aMUPA an approximately 20% reduction in eating coincided with a 16% increase in the median length of life, while in dietary restriction experiments 40% food restriction caused an approximately 35% increase of the median life span (Masoro et al., 1995) . The phenotypic manifestations of aMUPA mice are inversely related to those of the "Giant" transgenic mice carrying the gene encoding bovine growth hormone. These mice exhibited enhanced feeding and growth of body size and weight concomitantly with decreased longevity (Pendergrass et al., 1993) . aMUPA mice exhibited reduced food intake from weaning throughout at least 16 months of age. Food consumption of aMUPA mice was 90% that of WT shortly after weaning, it declined to 78% at 3-5 months, and was 69% at 16 months of age. Whether the apparent spontaneous decline with age in aMUPA feeding could exert any long-term beneficial effect on aMUPA aging is not known and deserves attention.
Another difference between aMUPA and WT mice was revealed when the diets of WT mice were adjusted to the reduced consumption patterns of aMUPA mice. Unlike aMUPA, the diet-restricted WT mice started to lose weight after about 70-80 days of age and became about 15% lighter than aMUPA. As both mouse groups eat the same amount of the same food, these data may indicate that aMUPA utilize the food in a more efficient manner and, furthermore, that this capability is inherent in aMUPA and was not acquired by WT mice during the experimental period of dietary restriction. Whether the survival curve of the diet-restricted WT will be similar or different from that of aMUPA is yet to be seen.
Food restriction in rodents was found to maintain many physiological processes in a youthful state and to retard ageassociated diseases and senescence (Masoro, 1992 (Masoro, , 1993 Weindruch, 1992) . aMUPA mice have not yet been studied for most of these parameters, though in accordance with data from dietary restricted animals (Masoro et al., 1995) , the blood glucose level of aMUPA was significantly lower than that of ad libitum-fed WT mice. Interestingly, when WT were fed the amount of food consumed by aMUPA, their mean 12-h blood sugar level was lower than that of aMUPA. This is compatible with the larger loss of body weight exhibited by the same dietary restricted WT mice. Longterm maintenance of low blood glucose levels was included among putative factors enhancing longevity upon dietary restriction (Masoro, 1993) . aMUPA also exhibited two changes related to reproductive behavior: smaller litter size and less frequent births.
Food restriction in rats was reported to decrease or have no effect upon the age-related decline in several learning tasks. In no case was it found to adversely affect cognitive capacities (Means et al., 1993 and references therein) . By contrast, aMUPA mice present a case where reduction in feeding was accompanied by learning deficits. We have previously shown that aMUPA were impaired in learning of spatial, olfactory, and taste aversion tasks while displaying normal sensory and motor capacities (Meiri et al., 1994) . We therefore propose the hypothesis that in aMUPA the phenotypic alterations in learning and food consumption are unrelated, each resulting from transgenic expression at a different brain site. Thus, excess uPA in the hippocampus, amygdala, and neocortex could interfere with learning and memory, while transgenic expression in the hypothalamic PVN is a candidate to influence feeding behavior. This hypothesis, however, has not been critically tested.
In the aMUPA hypothalamus, transgenic uPA mRNA has now been localized in the PVN, a region implicated in the control of food intake (Kyrkouli et al., 1986; Morley, 1987; Murakami etal., 1989; Kalraetal., 1991; Akabayashietal., 1994a) . In this site no transcriptional product of the normal uPA gene could be detected. We have not looked for the level of active enzyme specifically in the PVN; however, based on analysis conducted in other aMUPA brain sites (Meiri et al., 1994) , it is very likely that in the PVN transgenic uPA mRNA is translated into the active enzyme. Transgenic uPA could be envisioned to lead to reduced food intake through proteolytic intervention in the state of polypeptide neurotransmitters or surface receptors involved in the control of food consumption. Interference of uPA in the PVN-pituitary communication, whether through the abovementioned manners or otherwise, could lead to alteration of feeding behavior. Also, it cannot be excluded that the reduced feeding in aMUPA is determined through sites implicated in feeding behavior other than the PVN, such as the amygdala and the suprachiasmatic nucleus associated with circadian rhythms (Morley, 1987; Corwin et al., 1993 , Akabayashi et al., 1994b , where prominent transgenic expression was also found (Meiri et al., 1994) . The ectopic transgenic expression starts relatively late in embryonic life (embryonic day 17.5; Masos, T., and Miskin, R., unpublished results), prior, however, to the accomplishment of brain development. Therefore, it is possible that transgenic interference with development, especially in the abovementioned sites, also could affect food intake.
In the brain, extravascular plasminogen is thought to be present at a very low level (Nakajima et al., 1992; Sappino et al., 1993) . Therefore, it is not clear whether uPA would exert its proteolytic effect in the aMUPA brain through plasminogen activation or via a direct cleavage of other substrate molecules, as shown in the case of chicken fibronectin (Quigley et al., 1987) . We favor the latter possibility, because in the case of reduced body weight it looks as if the level of transgenic uPA is rate limiting rather than the level of the putative substrate for uPA. The dosage effect of transgenic uPA is inferred from the finding that the difference in body weight between WT and aMUPA homozygotes is approximately twice the difference between WT and aMUPA heterozygotes.
So far only one aMUPA line was generated and characterized; therefore, it could be claimed that the aMUPA phenotype is conferred by the position of transgenic insertion into the mouse genome rather than by the transgenic expression per se. Additional aMUPA lines are now in preparation to resolve this issue. Extracellular proteases, including the blood coagulation enzyme thrombin, were claimed to be involved in normal and pathological brain functions (for reviews, see Romanic and Madri, 1994; Smirnova et al., 1994) . The data presented here suggest that a protease of the fibrinolytic system could play a role in extravascular functions in the brain. Thus, the aMUPA phenotype raises the possibility that uPA in normal mice could be directly involved in biochemical brain mechanisms that determine food consumption, and secondarily to affect growth, weight, and longevity. aMUPA mice also provide a unique experimental system by which to study physiological and cellular parameters of spontaneously occurring prolonged aging, and to explore biochemical mechanisms linking food consumption and longevity. We thank Dr. Edna Schechtman for consultation on the statistical analysis.
